Quid Pro Quo (QPQ) Tracker
← Back to Influence Map
Entity DossierPAC

BRISTOL-MYERS SQUIBB COMPANY PAC (FKA: DUPONT PHARMACEUTICALS CO PAC)

Political action committee.

pharmaceuticals

Tracked direct giving

$7,000

View FEC cycle totals

Tracked receipts

Inflows not ingested

Connections

2

The Money Trail

How money flowed from BRISTOL-MYERS SQUIBB COMPANY PAC (FKA: DUPONT PHARMACEUTICALS CO PAC)

$7K
3 transactions across 2 counterparties
sum of 3 tracked donations shown
$7K tracked across 2 counterparties (sum of 3 tracked donations shown)
PAC Chain Attribution

Where BRISTOL-MYERS SQUIBB COMPANY PAC (FKA: DUPONT PHARMACEUTICALS CO PAC)’s money ended up

Attributed amounts are modeled estimates of how money flowed through intermediary PACs, computed by proportional apportionment of FEC-reported transactions. They are not reported transactions themselves. How we compute this

$2K
modeled estimate
1 path across 1 counterparty
$2Kmodeled estimateattributed to CLARKE FOR CONGRESS
2024 cycle1 path0 hopsHigh confidence

smallest single documented leg $1K

$2K attributed (modeled estimate) across 1 path·Up to 0 hops deep·Source FEC filings (Schedules A, B, E)·How we compute this
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Donations Given and Outside Spending

Largest 50 records. Rows badged “Spent to support” or “Spent to oppose” are independent expenditures this entity paid to vendors for or against the named candidate. That money was not given to them.

RecipientAmountDateCycle
CONGRESSIONAL BLACK CAUCUS POLITICAL ACTION COMMITTEE$5,000Sep 11, 20232024
CLARKE FOR CONGRESS$1,000Mar 31, 20232024
CLARKE FOR CONGRESS$1,000Oct 23, 20242024

Relationships

TypeConnected ToDetailsSource
Advocated forFinancial Innovation and Technology for the 21st Century Act (FIT21, H.R.4763)BRISTOL-MYERS SQUIBB COMPANY PAC (FKA: DUPONT PHARMACEUTICALS CO PAC) supported candidates who engaged with this policy outcomeEditorial
Advocated forGENIUS Act, Guiding and Establishing National Innovation for U.S. Stablecoins (S.394)BRISTOL-MYERS SQUIBB COMPANY PAC (FKA: DUPONT PHARMACEUTICALS CO PAC) supported candidates who engaged with this policy outcomeSource